United States · FDA National Drug Code directory
CEVIMELINE HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72888-118_473cb6cb-6b57-127c-e063-6394a90adbe8
- Product NDC
- 72888-118
- Form
- CAPSULE
- Composition / generic term
- CEVIMELINE HYDROCHLORIDE
- Labeler
- Advagen Pharma Ltd
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230406
- Source listing expiry
- 20261231
Source-listed ingredients
- CEVIMELINE HYDROCHLORIDE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 CAPSULE in 1 BOTTLE, PLASTIC (72888-118-00) · 72888-118-00
- 100 CAPSULE in 1 BOTTLE, PLASTIC (72888-118-01) · 72888-118-01
- 500 CAPSULE in 1 BOTTLE, PLASTIC (72888-118-05) · 72888-118-05
- 30 CAPSULE in 1 BOTTLE, PLASTIC (72888-118-30) · 72888-118-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →